The Immune System – News and Features

Eden will supply cGMP clinical manufacturing services to Onyvax for its Cell Vaccine program in ovarian cancer.

Aldevron purchases synDNA™ to offer a broader range of solutions to gene therapy and DNA vaccine researchers.

A combination of Pharming with DNage will generate important synergies in the area of business development and management expertise.

GE will provide CytoGenix with DNA production reagents for use in the manufacture of vaccines and therapeutic compounds by CytoGenix.

A team of computational and medicinal chemists at Tripos Discovery Research will work in partnership with Cara's project team.

The companies have elected to expand the scope of their collaboration to include an additional disease target.

This research tool is available for licensing for those who wish to use it within the biotechnology and pharmaceutical industry.

The Patent covers the composition and use of an oligonucleotide family for the treatment of cancer.

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.

The team, led by Bert Gold, Ph.D., and Michael Dean, Ph.D., of the National Cancer Institute, identified a genetic variant that is associated with an increased risk of developing AMD.